Would you consider a focal prostate boost per FLAME trial with treatment of the pelvis?  

The FLAME III trial evaluated a focal dose boost to the prostate tumor if it could be achieved without exceeding dose constraints. By extension, if you can achieve escalated dose to the tumor without meaningfully affecting your plan quality from an OAR perspective, I think this is a very reasonable ...